Back to SA Scion Asset Management, LLC
REGN2 quarters
Position history for SAScion Asset Management, LLC's holdings in Regeneron Pharmaceuticals, Inc.
No. Scion Asset Management exited its REGN (Regeneron Pharmaceuticals) position in Q3 2025. Its Q2 2025 13F listed 15,000 shares worth $7.9M. Scion Asset Management first reported REGN in Q2 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$7.9M
Total Shares Change
-15,000
Quarter-by-Quarter History
Other major holders of REGN: FMR LLC, VANGUARD GROUP INC